Mobile
Watch Now
Webinar

Decentralized Clinical Trials Event Featuring Massive Bio Co-Founder 

  • Arturo Loaiza-Bonilla
    Co-founder, Chief Medical Officer

Massive Bio Co-Founder and Chief Medical Officer Dr. Arturo Loaiza-Bonilla, MD, MSEd, was featured in Decentralized Clinical Trials: Accelerate Your Path to Proof of Concept with Increased Diversity, Accessibility, and Efficiency from Informa Connect. 

 

This event took place online virtually and in-person at the Hyatt Regency Coral Gables in Miami, Florida from June 6th to June 8th. Dr. Bonilla discussed the following topics in his presentation titled, “Using an AI-enabled Collaboration for Precision Oncology Decentralized Clinical Trials (DCT)”:
 

  • Challenges and opportunities in oncology and precision medicine around clinical trials 
  • Use of Artificial Intelligence (AI) and digital enabled technologies to implement a DCT strategy 
  • Case study of Pharma-CRO-Virtual Site-Massive Bio in a global DCT oncology trial 
  • Initiatives and Future perspectives 
  • Q&A with the audience 

 

https://twitter.com/DrBonillaOnc/status/1523237426063462400

 

In addition to being a Co-Founder of Massive Bio, Dr. Bonilla is a renowned medical oncologist and has a distinguished clinical career in precision medicine oncology, immunotherapy, clinical trial design, digital health, and patient advocacy.  

 

To watch full presentations from Decentralized Clinical Trials: Accelerate Your Path to Proof of Concept with Increased Diversity, Accessibility, and Efficiency including Using an AI-enabled Collaboration for Precision Oncology Decentralized Clinical Trials (DCT), visit Informa Connect’s website or submit the form on this page.  

o is hosting. Fill out the form to watch our webinar to learn more about the causes, treatments, new therapies, and more on esophageal cancer!  

Join our community
and receive our newsletter